Search
for

    Sort by

    Research 31–60 of 40

    1. Evaluation of Stigma Toward Individuals With Alopecia JAMA Dermatology · 2021 · 38 citations
    2. Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States Journal of Medical Economics · 2023 · 3 citations
    3. Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment Journal of Dermatological Treatment · 2026
    4. Monilethrix: A Novel Mutation (Glu402Lys) in the Helix Termination Motif and the First Causative Mutation (Asn114Asp) in the Helix Initiation Motif of the Type II Hair Keratin hHb6 Journal of Investigative Dermatology · 1999 · 29 citations
    5. Addressing Autoimmune and Immune-mediated Skin Disease Burden in Women Women's health issues · 2022
    6. Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata Journal of Investigative Dermatology Symposium Proceedings · 2020 · 4 citations
    7. Response to Ranpariya et al.’s “Direct-to-consumer teledermatology platforms may have inherent conflicts of interest.” Journal of The American Academy of Dermatology · 2022 · 1 citations
    8. Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint) JMIR Dermatology · 2025
    9. Patient satisfaction, side effects, and other reactions reported by adult men prescribed compounded, topical finasteride via a national telehealth platform: A retrospective analysis of real world data (Preprint) 2025
    10. Direct-to-consumer teledermatology’s limitations may be addressed with greater in-person care synergy 2022
    11. Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study Journal of Clinical and Diagnostic Research · 2023
    12. Local Corticosteroids for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025 · 8 citations
    13. Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials 2022 · 25 citations
    14. Association Between Natural Hair Color, Race, and Alopecia Dermatology and Therapy · 2024
    15. Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review Dermatology and Therapy · 2025
    16. Factors influencing alopecia areata treatment decisions: A qualitative assessment JAAD International · 2022 · 9 citations
    17. A mutation in the type II hair keratin KRT86 gene in a Han family with monilethrix 2011 · 3 citations
    18. Gender based price differences in 5% minoxidil foam: The impact of generic alternatives and bulk packaging Dermatology Online Journal · 2026
    19. Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States Advances in Therapy · 2022 · 7 citations
    20. Aromatase deficiency in a male patient - Case report and review of the literature. Bone · 2016 · 36 citations
    21. Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA Dermatology and Therapy · 2026
    22. Digital health platforms expand access and improve care for male androgenetic alopecia International Journal of Dermatology · 2022
    23. Online Traffic Analysis of Direct-to-Consumer Websites for Hair Loss Treatment and Characterization of Finasteride Patients on a Platform in Germany: A Potential Paradigm Shift in the Treatment of Androgenetic Alopecia Clinical, Cosmetic and Investigational Dermatology · 2023
    24. Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study DIGITAL HEALTH · 2023
    25. Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies Journal of the American Academy of Dermatology · 2024 · 2 citations
    26. Validation of alopecia coding in US claims data among women of childbearing age Pharmacoepidemiology and drug safety (Print) · 2024
    27. The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata Dermatology and Therapy · 2022 · 29 citations
    28. Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2 Annales de dermatologie et de vénéréologie, FMC · 2023
    29. Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA) SKIN The Journal of Cutaneous Medicine · 2025
    30. Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3 International Journal of Dermatology · 2025 · 1 citations